QuickView for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=01F0DC98EACACED76ED38E461B617655;jsessionid=CB97C4E2408B579C92CADF14B5EC6849 (gene)

1. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic …
2. Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangi…
3. Fgfr2 is integral for bladder mesenchyme patterning and function.
4. Keratinocyte growth factor receptor: a therapeutic target in solid cancer.
5. Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma.

There were no clinical trials for TK25;jsessionid=8C2ED186389585582270DBD8CC23FC32;jsessionid=01F0DC98EACACED76ED38E461B617655;jsessionid=CB97C4E2408B579C92CADF14B5EC6849